Niche CRO Services AVIVA Biosciences specializes in safety screening for ion channels and cardiovascular mechanics, presenting opportunities to offer specialized assay development, electrophysiology testing, and customized Langendorff-style formats to pharma and biotech clients conducting cardiac safety assessments.

Proprietary Platforms The RedSift Filter System and Sealchip16 voltage clamp technology represent unique capabilities that can be sold as core differentiators for clients needing non-traditional cytometry and high-throughput voltage-clamp data, enabling partnerships for assay development and translational research.

Rare Cell Focus AVIVA’s ability to recover >90% of total nucleated cells and analyze rare populations such as circulating tumor cells creates a sales angle with oncology, translational medicine, and liquid biopsy developers seeking robust cell isolation and characterization.

Customizable Solutions Flexible assay formats across multiple species and tissue types, including human tissue and clonal lines, position AVIVA to upsell tailored safety screening packages, broader ion channel profiling, and contract research collaborations with early-stage biotech companies.

Growth Funding Signals With reported revenue in the low to mid single digits and a clear emphasis on specialized safety screening, AVIVA may attract partners seeking agile CROs for focused cardiac electrophysiology studies, point-of-need services, and pilot projects aligned with emerging cardiovascular therapies.